Aviva Joseph

发表

A new intranasal influenza vaccine based on a novel polycationic lipid-ceramide carbamoyl-spermine (CCS). II. Studies in mice and ferrets and mechanism of adjuvanticity.

Rob Lambkin-Williams, A. Mann, Y. Barenholz, 2011, Vaccine.

cells by NKp46 The mechanisms controlling the recognition of tumor and virus infected

H. Achdout, O. Mandelboim, A. Porgador, 2013 .

The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46.

Angel Porgador, H. Achdout, O. Mandelboim, 2004, Blood.

A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice.

Y. Barenholz, D. Simberg, Aviva Joseph, 2006, Vaccine.

Inhibition of In Vivo HIV Infection in Humanized Mice by Gene Therapy of Human Hematopoietic Stem Cells with a Lentiviral Vector Encoding a Broadly Neutralizing Anti-HIV Antibody

G. Stiegler, R. Kunert, Aviva Joseph, 2010, Journal of Virology.

Engineering Antigen-Specific T Cells from Genetically Modified Human Hematopoietic Stem Cells in Immunodeficient Mice

O. Yang, J. Zack, Aviva Joseph, 2009, PloS one.

Immunogenicity and safety of a novel IL-2-supplemented liposomal influenza vaccine (INFLUSOME-VAC) in nursing-home residents.

Y. Barenholz, Aviva Joseph, E. Kedar, 2003, Vaccine.

Highly Active Antiretroviral Therapy Potently Suppresses HIV Infection in Humanized Rag2 -/- g c-/- Mice

K. Sango, Aviva Joseph, H. Goldstein, 2010 .

Liposomal immunostimulatory DNA sequence (ISS-ODN): an efficient parenteral and mucosal adjuvant for influenza and hepatitis B vaccines.

Y. Barenholz, E. Raz, Tomoko Hayashi, 2002, Vaccine.

Enhancement of the Immunoadjuvant Activity of Immunostimulatory DNA Sequence By Liposomal Delivery

Y. Barenholz, Tomoko Hayashi, Aviva Joseph, 2002 .

Short communication: Methamphetamine treatment increases in vitro and in vivo HIV replication.

L. Santambrogio, Aviva Joseph, H. Goldstein, 2009, AIDS research and human retroviruses.

Mucosal immunization against hepatitis A: antibody responses are enhanced by co-administration of synthetic oligodeoxynucleotides and a novel cationic lipid.

Y. Barenholz, Aviva Joseph, E. Kedar, 2006, Vaccine.

HLA-A2-Restricted HIV-1 Gag p24 Repertoire Specific for the Subdominant T Cell + Availability of a Diversely Avid CD8

F. Marincola, C. Brander, N. Frahm, 2017 .

Fine-tuning of T-cell receptor avidity to increase HIV epitope variant recognition by cytotoxic T lymphocytes

O. Yang, Aviva Joseph, H. Goldstein, 2010, AIDS.

Availability of a Diversely Avid CD8+ T Cell Repertoire Specific for the Subdominant HLA-A2-Restricted HIV-1 Gag p2419–27 Epitope1

M. Altfeld, F. Marincola, O. Yang, 2007, The Journal of Immunology.

Enhanced Recognition of Human NK Receptors After Influenza Virus Infection1

H. Achdout, O. Mandelboim, Aviva Joseph, 2003, The Journal of Immunology.

Novel mouse models for understanding HIV-1 pathogenesis.

K. Sango, Aviva Joseph, H. Goldstein, 2009, Methods in molecular biology.

Lentiviral Vectors Encoding Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Receptor Genes Efficiently Convert Peripheral Blood CD8 T Lymphocytes into Cytotoxic T Lymphocytes with Potent In Vitro and In Vivo HIV-1-Specific Inhibitory Activity

B. Walker, C. Brander, K. Sango, 2008, Journal of Virology.

Novel APC-like properties of human NK cells directly regulate T cell activation

J. Hanna, O. Mandelboim, D. Mevorach, 2015, bioRxiv.

Generation of robust CD8+ T‐cell responses against subdominant epitopes in conserved regions of HIV‐1 by repertoire mining with mimotopes

F. Marincola, J. Sidney, A. Sette, 2010, European journal of immunology.

Highly active antiretroviral therapy potently suppresses HIV infection in humanized Rag2-/-gammac-/- mice.

K. Sango, Aviva Joseph, H. Goldstein, 2010, AIDS research and human retroviruses.

Immunogenicity and safety of a novel liposomal influenza subunit vaccine (INFLUSOME‐VAC) in young adults

Y. Barenholz, Aviva Joseph, E. Kedar, 2003, Journal of medical virology.

Characterization and in vivo performance of dextran-spermine polyplexes and DOTAP/cholesterol lipoplexes administered locally and systemically.

Y. Barenholz, A. Domb, Aviva Joseph, 2007, Biomaterials.

This information is current as Receptors After Influenza Virus Infection Enhanced Recognition of Human

H. Achdout, O. Mandelboim, Aviva Joseph, 2003 .

A new intranasal influenza vaccine based on a novel polycationic lipid-ceramide carbamoyl-spermine (CCS). II. Studies in mice and ferrets and mechanism of adjuvanticity.

Rob Lambkin-Williams, A. Mann, Y. Barenholz, 2011, Vaccine.